Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zevra Therapeutics (ZVRA) Revenue: 2013-2024

Historic Revenue for Zevra Therapeutics (ZVRA) over the last 12 years, with Dec 2024 value amounting to $23.6 million.

  • Zevra Therapeutics' Revenue rose 605.41% to $26.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $84.4 million, marking a year-over-year increase of 244.63%. This contributed to the annual value of $23.6 million for FY2024, which is 14.02% down from last year.
  • According to the latest figures from FY2024, Zevra Therapeutics' Revenue is $23.6 million, which was down 14.02% from $27.5 million recorded in FY2023.
  • In the past 5 years, Zevra Therapeutics' Revenue ranged from a high of $28.6 million in FY2021 and a low of $10.2 million during FY2022.
  • In the last 3 years, Zevra Therapeutics' Revenue had a median value of $23.6 million in 2024 and averaged $20.4 million.
  • In the last 5 years, Zevra Therapeutics' Revenue slumped by 64.53% in 2022 and then spiked by 170.26% in 2023.
  • Zevra Therapeutics' Revenue (Yearly) stood at $13.3 million in 2020, then soared by 115.61% to $28.6 million in 2021, then slumped by 64.53% to $10.2 million in 2022, then surged by 170.26% to $27.5 million in 2023, then dropped by 14.02% to $23.6 million in 2024.